Anomalous expression of Thy1 (CD90) in B-cell lymphoma cells and proliferation inhibition by anti-Thy1 antibody treatment

Biochemical and Biophysical Research Communications

Volumn 396, Issue 2, 2010, Pages 329-334

  Ishiura, Yoshihito ^a,b   Kotani, Norihiro ^a,b   Yamashita, Ryusuke ^a,b   Yamamoto, Harumi ^c   Kozutsumi, Yasunori ^b,c   Honke, Koichi ^a,b  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

B cell lymphoma; Glycogene; Lipid raft; Rituximab; Thy1

Indexed keywords

MONOCLONAL ANTIBODY; RITUXIMAB; THY 1 ANTIBODY; THY 1 ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE ARREST; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; DRUG CYTOTOXICITY; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; LIPID RAFT; LYMPHOMA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UPREGULATION; WESTERN BLOTTING;

ANTIGENS, NEOPLASM; ANTIGENS, THY-1; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOTOXICITY, IMMUNOLOGIC; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; ISOANTIBODIES; LYMPHOMA, B-CELL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; UP-REGULATION;

HUMAN HERPESVIRUS 4;

EID: 77952746128     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.04.092     Document Type: Article

References (31)

1. White C., Weaver R., and Grillo-López A. Antibody-targeted immunotherapy for treatment of malignancy. Annu. Rev. Med. 52 (2001) 125-145
2. Slamon D., Clark G., Wong S., Levin W., Ullrich A., and McGuire W. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235 (1987) 177-182
3. Press O., Appelbaum F., Ledbetter J., Martin P., Zarling J., Kidd P., and Thomas E. Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas. Blood 69 (1987) 584-591
4. Maloney D., Liles T., Czerwinski D., Waldichuk C., Rosenberg J., Grillo-Lopez A., and Levy R. Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma. Blood 84 (1994) 2457-2466
5. Reff M., Carner K., Chambers K., Chinn P., Leonard J., Raab R., Newman R., Hanna N., and Anderson D. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 83 (1994) 435-445
6. Epstein M., Achong B., and Barr Y. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet (1964) 702-703
7. Fukayama M., Ibuka T., Hayashi Y., Ooba T., Koike M., and Mizutani S. Epstein-Barr virus in pyothorax-associated pleural lymphoma. Am. J. Pathol. 143 (1993) 1044-1049
8. Rickinson A.B., and Kieff E. Epstein-Barr virus. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology (2006), Lippincott, Philadelphia 2655-2700
9. Kieff E., and Rickinson A.B. Epstein-Barr virus and its replication. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology (2006), Lippincott, Philadelphia 2603-2654
10. In: Taniguchi N., Honke K., and Fukuda M. (Eds). Handbook of Glycosyltransferases and Related Genes (2002), Springer-Verlag, Tokyo
11. Ide Y., Miyoshi E., Nakagawa T., Gu J., Tanemura M., Nishida T., Ito T., Yamamoto H., Kozutsumi Y., and Taniguchi N. Aberrant expression of N-acetylglucosaminyltransferase-IVa and IVb (GnT-IVa and b) in pancreatic cancer. Biochem. Biophys. Res. Commun. 341 (2006) 478-482
12. Yamamoto H., Takematsu H., Fujinawa R., Naito Y., Okuno Y., Tsujimoto G., Suzuki A., and Kozutsumi Y. Correlation index-based responsible-enzyme gene screening (CIRES), a novel DNA microarray-based method for enzyme gene involved in glycan biosynthesis. PLoS ONE 2 (2007) e1232
13. Reif A.A., and Allen J. The AKR thymic antigen and its distribution in leukemias and nervous tissues. J. Exp. Med. 120 (1964) 413-433
14. Reif A., and Allen J. Mouse thymic iso-antigens. Nature 209 (1966) 521-523
15. Harder T., Scheiffele P., Verkade P., and Simons K. Lipid domain structure of the plasma membrane revealed by patching of membrane components. J. Cell Biol. 141 (1998) 929-942
16. Rege T., and Hagood J. Thy-1, a versatile modulator of signaling affecting cellular adhesion, proliferation, survival, and cytokine/growth factor responses. Biochim. Biophys. Acta 1763 (2006) 991-999
17. Craig W., Kay R., Cutler R., and Lansdorp P. Expression of Thy-1 on human hematopoietic progenitor cells. J. Exp. Med. 177 (1993) 1331-1342
18. Rege T., and Hagood J. Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis. FASEB J. 20 (2006) 1045-1054
19. Fujita N., Kato Y., Naito M., and Tsuruo T. A novel anti-Thy-1 (CD90) monoclonal antibody induces apoptosis in mouse malignant T-lymphoma cells in spite of inducing bcl-2 expression. Int. J. Cancer 66 (1996) 544-550
20. Alas S., Emmanouilides C., and Bonavida B. Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis. Clin. Cancer Res. 7 (2001) 709-723
21. Haeryfar S., Al-Alwan M., Mader J., Rowden G., West K., and Hoskin D. Thy-1 signaling in the context of costimulation provided by dendritic cells provides signal 1 for T cell proliferation and cytotoxic effector molecule expression, but fails to trigger delivery of the lethal hit. J. Immunol. 171 (2003) 69-77
22. Morita H., Isobe K., Cai Z., Miyazaki T., Matsumoto Y., Shinzato T., Yoshikai Y., Kimata K., and Maeda K. Thy-1 antigen mediates apoptosis of rat glomerular cells in vitro and in vivo. Nephron 73 (1996) 293-298
23. Shimizu A., Masuda Y., Kitamura H., Ishizaki M., Ohashi R., Sugisaki Y., and Yamanaka N. Complement-mediated killing of mesangial cells in experimental glomerulonephritis: cell death by a combination of apoptosis and necrosis. Nephron 86 (2000) 152-160
24. Jefferson J., and Johnson R. Experimental mesangial proliferative glomerulonephritis (the anti-Thy-1.1 model). J. Nephrol. 12 (1999) 297-307
25. Wu C., Ying H., Grinnell C., Bryant S., Miller R., Clabbers A., Bose S., McCarthy D., Zhu R., Santora L., Davis-Taber R., Kunes Y., Fung E., Schwartz A., Sakorafas P., Gu J., Tarcsa E., Murtaza A., and Ghayur T. Simultaneous targeting of multiple disease mediators by a dual-variable-domain immunoglobulin. Nat. Biotechnol. 25 (2007) 1290-1297
26. Qu Z., Goldenberg D., Cardillo T., Shi V., Hansen H., and Chang C. Bispecific anti-CD20/22 antibodies inhibit B-cell lymphoma proliferation by a unique mechanism of action. Blood 111 (2008) 2211-2219
27. Kotani N., Gu J., Isaji T., Udaka K., Taniguchi N., and Honke K. Biochemical visualization of cell surface molecular clustering in living cells. Proc. Natl. Acad. Sci. USA 105 (2008) 7405-7409
28. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 103 (2000) 211-225
29. Li Z., Zhu Y., Plowright E., Bergsagel P., Chesi M., Patterson B., Hawley T., Hawley R., and Stewart A. The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cells. Blood 97 (2001) 2413-2419
30. Karabatsou K., Pal P., Dodd S., Mat A., Haylock B., Aguirreburualde M., Moxam N., Pinson-Ellis W., Broome J., and Rainov N. Expression of survivin, platelet-derived growth factor A (PDGF-A) and PDGF receptor alpha in primary central nervous system lymphoma. J. Neurooncol. 79 (2006) 171-179
31. Renné C., Minner S., Küppers R., Hansmann M., and Bräuninger A. Autocrine NGFbeta/TRKA signalling is an important survival factor for Hodgkin lymphoma derived cell lines. Leuk. Res. 32 (2008) 163-167